SEATTLE, WA--(Marketwire - April 25, 2008) - Targeted Genetics Corporation (NASDAQ: TGEN) today announced that it received a staff deficiency letter from the Nasdaq Stock Market on April 23, 2008 indicating that, for the last 30 consecutive business days, the bid price of Targeted Genetics’ common stock has closed below the minimum $1.00 per share requirement for continued listing under Marketplace Rule 4310(c)(4).
